Zynex Financials

ZYXI Stock  USD 8.08  0.19  2.30%   
Based on the key measurements obtained from Zynex's financial statements, Zynex Inc is performing exceptionally good at this time. It has a great probability to report excellent financial results in March. As of now, Zynex's Other Current Assets are increasing as compared to previous years. The Zynex's current Other Stockholder Equity is estimated to increase to about 23.3 M, while Common Stock Shares Outstanding is projected to decrease to under 28.8 M. Key indicators impacting Zynex's financial strength include:
Current ValueLast YearChange From Last Year 10 Year Trend
Current Ratio4.484.27
Sufficiently Up
Slightly volatile
Investors should never underestimate Zynex's ability to pay suppliers on time, ensure interest payments are not accumulating, and correctly time where and how to reinvest extra cash. Individual investors need to monitor Zynex's cash flow, debt, and profitability to make informed and accurate decisions about investing in Zynex Inc.

Net Income

11.75 Million

  
Understanding current and past Zynex Financials, including the trends in assets, liabilities, equity and income are directly related to making proper and timely investing decisions. All of Zynex's financial statements are interrelated, with each one affecting the others. For example, an increase in Zynex's assets may result in an increase in income on the income statement.

Zynex Stock Summary

Zynex competes with Henry Schein, Owens Minor, Cardinal Health, Patterson Companies, and McKesson. Zynex, Inc., through its subsidiaries, designs, manufactures, and markets medical devices to treat chronic and acute pain and activate and exercise muscles for rehabilitative purposes with electrical stimulation. Zynex, Inc. was founded in 1996 and is headquartered in Englewood, Colorado. Zynex operates under Medical Distribution classification in the United States and is traded on NASDAQ Exchange. It employs 774 people.
Specialization
Health Care, Health Care Equipment & Services
InstrumentUSA Stock View All
ExchangeNASDAQ Exchange
ISINUS98986M1036
CUSIP98986M103
LocationColorado; U.S.A
Business Address9655 Maroon Circle,
SectorHealth Care Equipment & Supplies
IndustryHealth Care
BenchmarkDow Jones Industrial
Websitewww.zynex.com
Phone303 703 4906
CurrencyUSD - US Dollar

Zynex Key Financial Ratios

Zynex Key Balance Sheet Accounts

202020212022202320242025 (projected)
Total Assets72.2M133.3M116.5M136.9M157.4M165.3M
Retained Earnings23.4M0.017.0M26.8M30.8M32.3M
Other Current Assets2.8M1.4M868K3.3M3.8M4.0M
Total Current Assets63.0M82.7M69.6M87.9M101.0M106.1M
Total Liab15.3M59.3M50.1M90.8M104.4M109.6M
Other Current Liab864K4.5M5.5M5.5M6.4M6.7M
Net Debt(31.8M)(7.5M)6.8M31.6M28.4M29.9M
Accounts Payable4.7M4.7M5.6M8.4M9.7M10.2M
Net Receivables13.8M28.6M35.1M26.8M30.9M32.4M
Inventory8.6M10.8M13.5M13.1M15.1M15.8M
Short Term Debt4.3M11.3M7.9M3.9M4.5M3.0M
Cash39.2M42.6M20.1M44.6M51.3M53.8M
Other Assets913K1.3M2.2M1.01.151.09
Net Tangible Assets19.7M56.9M43.5M36.9M42.4M44.5M
Capital Surpluse9.2M37.2M80.4M82.4M94.8M99.5M

Zynex Key Income Statement Accounts

202020212022202320242025 (projected)
Interest Expense19K95K440K1.1M1.3M1.3M
Total Revenue80.1M130.3M158.2M184.3M212.0M222.6M
Gross Profit62.7M103.0M126.2M146.0M167.8M176.2M
Operating Income10.2M22.4M22.9M10.8M12.4M13.0M
Ebit10.2M22.4M22.9M13.7M15.7M16.5M
Ebitda11.7M24.7M26.1M17.9M20.6M21.6M
Cost Of Revenue17.4M27.3M32.0M38.4M44.1M46.3M
Income Before Tax10.2M22.3M22.2M12.6M14.5M15.2M
Net Income9.1M17.1M17.0M9.7M11.2M11.8M
Income Tax Expense1.1M5.2M5.2M2.8M3.3M3.4M
Research Development800K2.6M7.1M9.2M10.6M11.1M
Tax Provision1.1M5.2M5.2M4.4M5.1M5.3M
Net Interest Income(19K)(95K)(440K)(823K)(946.5K)(899.1K)

Zynex Key Cash Accounts

202020212022202320242025 (projected)
Change To Inventory(7.3M)(3.8M)(4.3M)(1.4M)(1.3M)(1.4M)
Change In Cash25.1M3.4M(22.5M)24.4M28.1M29.5M
Free Cash Flow(167K)6.3M13.3M16.6M19.0M20.0M
Depreciation1.6M2.3M3.1M4.2M4.9M5.1M
Other Non Cash Items(236K)1.3M1.2M(2.1M)(1.9M)(1.8M)
Capital Expenditures985K609K418K1.2M1.4M1.5M
Net Income9.1M17.1M17.0M9.7M11.2M11.8M
End Period Cash Flow39.2M42.6M20.1M44.6M51.3M53.8M
Change To Netincome1.2M2.6M1.5M1.8M2.1M1.3M
Change Receivables(3.0M)(8.0M)(14.8M)(6.4M)(5.8M)(5.5M)
Net Borrowings(19K)(57K)16.0M(5.3M)(6.1M)(5.8M)
Investments(985K)(16.6M)(418K)(10.5M)(9.4M)(9.0M)
Dividends Paid412K1K3.6M(3K)(2.7K)(2.6K)

Zynex Financial Ratios Relationships

Comparative valuation techniques use various fundamental indicators to help in determining Zynex's current stock value. Our valuation model uses many indicators to compare Zynex value to that of its competitors to determine the firm's financial worth. You can analyze the relationship between different fundamental ratios across Zynex competition to find correlations between indicators driving Zynex's intrinsic value. More Info.
Zynex Inc is rated third in return on equity category among its peers. It is rated third in return on asset category among its peers reporting about  0.39  of Return On Asset per Return On Equity. The ratio of Return On Equity to Return On Asset for Zynex Inc is roughly  2.56 . As of now, Zynex's Return On Equity is decreasing as compared to previous years. The reason why the comparable model can be used in almost all circumstances is due to the vast number of multiples that can be utilized, such as the price-to-earnings (P/E), price-to-book (P/B), price-to-sales (P/S), price-to-cash flow (P/CF), and many others. The P/E ratio is the most commonly used of these ratios because it focuses on the Zynex's earnings, one of the primary drivers of an investment's value.

Zynex Inc Systematic Risk

Zynex's systematic risk plays a vital role in portfolio allocation when considering its stock to be added to a well-diversified portfolio. Zynex volatility which cannot be eliminated through diversification, requires returns over the risk-free rate. Over the long run, a well-diversified portfolio provides returns that match its exposure to systematic risk. In this case, investors face a trade-off between expected returns and systematic risk and, therefore, can only reduce a portfolio's exposure to systematic risk by sacrificing expected returns on the portfolio.
The output start index for this execution was thirty with a total number of output elements of thirty-one. The Beta measures systematic risk based on how returns on Zynex Inc correlated with the market. If Beta is less than 0 Zynex generally moves in the opposite direction as compared to the market. If Zynex Beta is about zero movement of price series is uncorrelated with the movement of the benchmark. if Beta is between zero and one Zynex Inc is generally moves in the same direction as, but less than the movement of the market. For Beta = 1 movement of Zynex is generally in the same direction as the market. If Beta > 1 Zynex moves generally in the same direction as, but more than the movement of the benchmark.
Today, most investors in Zynex Stock are looking for potential investment opportunities by analyzing not only static indicators but also various Zynex's growth ratios. Consistent increases or decreases in fundamental ratios usually indicate a possible pattern that can be successfully translated into profits. However, when comparing two companies, knowing each company's growth growth rates may not be enough to decide which company is a better investment. That's why investors frequently use static breakdown of Zynex growth as a starting point in their analysis.

Price Earnings To Growth Ratio

(1.12)

As of now, Zynex's Price Earnings To Growth Ratio is decreasing as compared to previous years.

Zynex January 30, 2025 Opportunity Range

Along with financial statement analysis, the daily predictive indicators of Zynex help investors to analyze its daily demand and supply, volume, patterns, and price swings to determine the real value of Zynex Inc. We use our internally-developed statistical techniques to arrive at the intrinsic value of Zynex Inc based on widely used predictive technical indicators. In general, we focus on analyzing Zynex Stock price patterns and their correlations with different microeconomic environment and drivers. We also apply predictive analytics to build Zynex's daily price indicators and compare them against related drivers.

Complementary Tools for Zynex Stock analysis

When running Zynex's price analysis, check to measure Zynex's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Zynex is operating at the current time. Most of Zynex's value examination focuses on studying past and present price action to predict the probability of Zynex's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Zynex's price. Additionally, you may evaluate how the addition of Zynex to your portfolios can decrease your overall portfolio volatility.
Equity Valuation
Check real value of public entities based on technical and fundamental data
Pattern Recognition
Use different Pattern Recognition models to time the market across multiple global exchanges
Sectors
List of equity sectors categorizing publicly traded companies based on their primary business activities
Efficient Frontier
Plot and analyze your portfolio and positions against risk-return landscape of the market.
Cryptocurrency Center
Build and monitor diversified portfolio of extremely risky digital assets and cryptocurrency
Pair Correlation
Compare performance and examine fundamental relationship between any two equity instruments
Bond Analysis
Evaluate and analyze corporate bonds as a potential investment for your portfolios.
Economic Indicators
Top statistical indicators that provide insights into how an economy is performing